Ibuprofen may decrease the excretion rate of GPX-150 which could result in a higher serum level. The metabolism of Ibuprofen can be decreased when combined with Clotrimazole. The risk or severity of adverse effects can be increased when Fenoprofen is combined with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Nilotinib. The metabolism of Ibuprofen can be increased when combined with Lopinavir. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Deflazacort. The metabolism of Ibuprofen can be decreased when combined with Losartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluticasone furoate. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etofenamate. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Aldosterone. Ibuprofen may decrease the antihypertensive activities of Triamterene. The risk or severity of adverse effects can be increased when Moexipril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prednisolone. The metabolism of Ibuprofen can be decreased when combined with Manidipine. The metabolism of Ibuprofen can be decreased when combined with Irbesartan. The risk or severity of adverse effects can be increased when Fosinopril is combined with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Dextran 70. The serum concentration of Digoxin can be increased when it is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Formestane. The metabolism of Ibuprofen can be decreased when combined with Fluorouracil. The risk or severity of adverse effects can be increased when Etanercept is combined with Ibuprofen. The therapeutic efficacy of Alprostadil can be decreased when used in combination with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Dextran. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Mometasone. The risk or severity of adverse effects can be increased when Treprostinil is combined with Ibuprofen. The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prednisone. Ibuprofen may increase the anticoagulant activities of Protocatechualdehyde. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Castanospermine. The metabolism of Ibuprofen can be increased when combined with Phenytoin. The metabolism of Ibuprofen can be decreased when combined with Isoniazid. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Metamizole. The therapeutic efficacy of Sulprostone can be decreased when used in combination with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Chloramphenicol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with HE3286. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tiludronic acid. Ibuprofen may decrease the excretion rate of Plazomicin which could result in a higher serum level. Ibuprofen may increase the anticoagulant activities of Fondaparinux sodium. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Dexamethasone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Semapimod. Colesevelam can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy. The metabolism of Ibuprofen can be decreased when combined with Omeprazole. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Salicylamide. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Flunisolide. Ibuprofen may increase the anticoagulant activities of Edoxaban. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Cortexolone 17α-propionate. Ibuprofen may decrease the antihypertensive activities of Esmolol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etoricoxib. The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Lisinopril is combined with Ibuprofen. Ibuprofen may decrease the diuretic activities of Piretanide. Ibuprofen may decrease the diuretic activities of Etacrynic acid. The risk or severity of adverse effects can be increased when Rescinnamine is combined with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Pentaerythritol Tetranitrate. Ibuprofen may increase the anticoagulant activities of Dicoumarol. Ibuprofen may increase the nephrotoxic activities of Olsalazine. Ibuprofen may increase the anticoagulant activities of Reviparin. The risk or severity of adverse effects can be increased when Masoprocol is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Bevantolol. Ibuprofen may increase the anticoagulant activities of Pentosan Polysulfate. The metabolism of Ibuprofen can be decreased when combined with Stiripentol. The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Ibuprofen. Ibuprofen may increase the neuroexcitatory activities of Gemifloxacin. The metabolism of Ibuprofen can be decreased when combined with Lovastatin. Ibuprofen may decrease the antihypertensive activities of Alprenolol. The serum concentration of Lithium can be increased when it is combined with Ibuprofen. The serum concentration of Ibuprofen can be increased when it is combined with Lumacaftor. The risk or severity of adverse effects can be increased when Forasartan is combined with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Antithrombin III human. The metabolism of Ibuprofen can be decreased when combined with Indinavir. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Ibuproxam. Ibuprofen may decrease the antihypertensive activities of Bopindolol. Ibuprofen may increase the anticoagulant activities of Phenprocoumon. Ibuprofen may decrease the excretion rate of Paromomycin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tinoridine. Ibuprofen may decrease the antihypertensive activities of Amiloride. The risk or severity of adverse effects can be increased when Ramipril is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Carteolol. The serum concentration of Ibuprofen can be increased when it is combined with Probenecid. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Risedronate. The metabolism of Ibuprofen can be decreased when combined with Nelfinavir. The therapeutic efficacy of Misoprostol can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Equilenin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fenbufen. Ibuprofen may increase the anticoagulant activities of Desirudin. The risk or severity of adverse effects can be increased when Rofecoxib is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Antipyrine. The risk or severity of adverse effects can be increased when Enalapril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Piroxicam is combined with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Bortezomib. The risk or severity of adverse effects can be increased when Meloxicam is combined with Ibuprofen. The therapeutic efficacy of Unoprostone can be decreased when used in combination with Ibuprofen. The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Magnesium salicylate. The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Tolbutamide. The serum concentration of Vancomycin can be increased when it is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etidronic acid. The metabolism of Ibuprofen can be increased when combined with Fosphenytoin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with SRT501. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Methylprednisolone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Desoximetasone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Salsalate. The risk or severity of adverse effects can be increased when Sacubitril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Seratrodast. The risk or severity of adverse effects can be increased when Nabumetone is combined with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Ticagrelor. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Triamcinolone. The metabolism of Ibuprofen can be decreased when combined with Rabeprazole. Colestipol can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy. The metabolism of Ibuprofen can be increased when combined with Rifampicin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Indoprofen. The metabolism of Ibuprofen can be decreased when combined with Celecoxib. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Indobufen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Resveratrol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluticasone propionate. The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tolfenamic Acid. The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Anisodamine. Ibuprofen may decrease the antihypertensive activities of Celiprolol. The metabolism of Ibuprofen can be decreased when combined with Sulfamethoxazole. Ibuprofen may increase the nephrotoxic activities of Cyclosporine. Ibuprofen may decrease the excretion rate of Neomycin which could result in a higher serum level. Ibuprofen may decrease the antihypertensive activities of Talinolol. Ibuprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level. The therapeutic efficacy of Latanoprost can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Floctafenine is combined with Ibuprofen.